Full Text
PCN24 ECONOMIC EVALUATION OF SORAFENIB VERSUS BEST SUPPORTIVE CARE IN ADVANCED RENAL CELL CARCINOMA- AN UPDATED COST-EFFECTIVENESS ANALYSIS

Abstract

Authors

X Gao S Shah P Reddy K Gondek CL Pashos

Back to Volume 11, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×